OM DENNE EPISODE
Veeva's Florian Schnappauf speaks to Andy Eeckhout of ADVANZ PHARMA about ensuring launch success. Preparing for a launch is a high-stakes gamble for all biopharma companies, particularly those focused on rare diseases. Andy explains how ADVANZ uses data to prepare for a launch, scale across multiple markets, and help MSLs get up-to-speed quickly for an in-depth scientific discussion with experts.
Engelsk
USA
UDSKRIFT 🔗
1
00:00:00,208 --> 00:00:03,375
(bright upbeat music)
2
00:00:08,640 --> 00:00:10,620
- Hello everyone, and thank you very much
3
00:00:10,620 --> 00:00:13,443
for joining today's podcast episode.
4
00:00:14,340 --> 00:00:15,990
We have an exciting topic today.
5
00:00:15,990 --> 00:00:19,260
We're going to be talking
about launch in commercial
6
00:00:19,260 --> 00:00:21,270
and specifically in rare diseases,
7
00:00:21,270 --> 00:00:24,360
and I'm very, very
pleased to be joined today
8
00:00:…
00:00:00,208 --> 00:00:03,375
(bright upbeat music)
2
00:00:08,640 --> 00:00:10,620
- Hello everyone, and thank you very much
3
00:00:10,620 --> 00:00:13,443
for joining today's podcast episode.
4
00:00:14,340 --> 00:00:15,990
We have an exciting topic today.
5
00:00:15,990 --> 00:00:19,260
We're going to be talking
about launch in commercial
6
00:00:19,260 --> 00:00:21,270
and specifically in rare diseases,
7
00:00:21,270 --> 00:00:24,360
and I'm very, very
pleased to be joined today
8
00:00:…
SØG BLANDT TIDLIGERE EPISODER
Søg efter gamle afsnit af What Pharma Needs Next.
Ansvarsfraskrivelse: Podcasten og kunstværket, der er indlejret på denne side, er fra Veeva Systems, som tilhører dens ejer og ikke er tilknyttet eller godkendt af Listen Notes, Inc.
REDIG
Tak fordi du hjælper med at holde podcast-databasen opdateret.